181 related articles for article (PubMed ID: 9434579)
1. [AGE receptor].
Matsumoto K; Sano H; Horiuchi S
Nihon Rinsho; 1997 Nov; 55 Suppl():867-71. PubMed ID: 9434579
[No Abstract] [Full Text] [Related]
2. Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptors.
Vlassara H; Bucala R
Diabetes; 1996 Jul; 45 Suppl 3():S65-6. PubMed ID: 8674896
[TBL] [Abstract][Full Text] [Related]
3. A new dark side of the Maillard's products.
Wautier JL
Diabetes Metab; 2003 Feb; 29(1):86-7. PubMed ID: 12629454
[No Abstract] [Full Text] [Related]
4. Glycation as the glucose link to diabetic complications.
Gugliucci A
J Am Osteopath Assoc; 2000 Oct; 100(10):621-34. PubMed ID: 11105451
[TBL] [Abstract][Full Text] [Related]
5. [Participation of toxic AGEs (TAGE) in a variety of diseases].
Takeuchi M
Nihon Yakurigaku Zasshi; 2012 May; 139(5):193-7. PubMed ID: 22687870
[No Abstract] [Full Text] [Related]
6. Unlocking the biology of RAGE in diabetic microvascular complications.
Manigrasso MB; Juranek J; Ramasamy R; Schmidt AM
Trends Endocrinol Metab; 2014 Jan; 25(1):15-22. PubMed ID: 24011512
[TBL] [Abstract][Full Text] [Related]
7. [Oxidative stress in diabetes].
Mizuta M
Nihon Yakurigaku Zasshi; 2005 Mar; 125(3):125-8. PubMed ID: 15855729
[No Abstract] [Full Text] [Related]
8. Molecular mechanisms of diabetic angiopathy--clues for innovative therapeutic interventions.
Bierhaus A; Ziegler R; Nawroth PP
Horm Res; 1998; 50 Suppl 1():1-5. PubMed ID: 9676989
[TBL] [Abstract][Full Text] [Related]
9. Recent progress in advanced glycation end products and diabetic complications.
Vlassara H
Diabetes; 1997 Sep; 46 Suppl 2():S19-25. PubMed ID: 9285494
[No Abstract] [Full Text] [Related]
10. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.
Basta G; Sironi AM; Lazzerini G; Del Turco S; Buzzigoli E; Casolaro A; Natali A; Ferrannini E; Gastaldelli A
J Clin Endocrinol Metab; 2006 Nov; 91(11):4628-34. PubMed ID: 16926247
[TBL] [Abstract][Full Text] [Related]
11. Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis.
Satheesan S; Figarola JL; Dabbs T; Rahbar S; Ermel R
Br J Pharmacol; 2014 Jun; 171(12):3103-14. PubMed ID: 24611770
[TBL] [Abstract][Full Text] [Related]
12. Role of advanced glycation end products in cellular signaling.
Ott C; Jacobs K; Haucke E; Navarrete Santos A; Grune T; Simm A
Redox Biol; 2014; 2():411-29. PubMed ID: 24624331
[TBL] [Abstract][Full Text] [Related]
13. Regulation of RAGE for attenuating progression of diabetic vascular complications.
Win MT; Yamamoto Y; Munesue S; Saito H; Han D; Motoyoshi S; Kamal T; Ohara T; Watanabe T; Yamamoto H
Exp Diabetes Res; 2012; 2012():894605. PubMed ID: 22110482
[TBL] [Abstract][Full Text] [Related]
14. Protein glycation: a firm link to endothelial cell dysfunction.
Wautier JL; Schmidt AM
Circ Res; 2004 Aug; 95(3):233-8. PubMed ID: 15297385
[TBL] [Abstract][Full Text] [Related]
15. Blockade of diabetic vascular injury by controlling of AGE-RAGE system.
Myint KM; Yamamoto Y; Sakurai S; Harashima A; Watanabe T; Li H; Takeuchi A; Yoshimura K; Yonekura H; Yamamoto H
Curr Drug Targets; 2005 Jun; 6(4):447-52. PubMed ID: 16026264
[TBL] [Abstract][Full Text] [Related]
16. Expression of receptors for advanced glycation end-products in occlusive vascular and renal disease.
Bierhaus A; Ritz E; Nawroth PP
Nephrol Dial Transplant; 1996; 11 Suppl 5():87-90. PubMed ID: 9044315
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms.
Grossin N; Wautier MP; Picot J; Stern DM; Wautier JL
Diabetes Metab; 2009 Nov; 35(5):410-7. PubMed ID: 19815443
[TBL] [Abstract][Full Text] [Related]
19. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM
Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300
[TBL] [Abstract][Full Text] [Related]
20. AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice.
Gao X; Zhang H; Schmidt AM; Zhang C
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H491-8. PubMed ID: 18539754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
